Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Neurotoxicity Syndromes × Exercise Therapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 6 Motor Activity 5 Fatigue 3 Depression 3 Breast Cancer Lymphedema 2 Anxiety Disorders 2 Stomach Neoplasms 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pancreatic Neoplasms 1 Pain 1 Osteosclerosis 1 Osteoarthritis, Knee 1 Neurotoxicity Syndromes 1 Neoplasms 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Lymphoma, Follicular 1 Lymphoma 1 Lymphedema 1 Lung Neoplasms 1 Kinesiophobia 1 Head and Neck Neoplasms 1 Chronic Pain 1 Carcinoma, Non-Small-Cell Lung 1 Bone Neoplasms 1 Body Weight Changes 1 Arthritis 1 Accessory Nerve Injuries 1

Interventions

Paclitaxel 5 Vincristine 3 Carboplatin 3 Amifostine 3 xaliproden 2 glucarpidase 2 Taxes 2 Radiotherapy 2 Psychiatric Rehabilitation 2 Procarbazine 2 Methotrexate 2 Mental Status and Dementia Tests 2 Magnetic Resonance Spectroscopy 2 Leucovorin 2 Doxorubicin 2 Cyclophosphamide 2 Cisplatin 2 2,2'-dithiodiethanesulfonic acid 2 neurotropin 1 glutamic acid diethyl ester 1 eribulin 1 axicabtagene ciloleucel 1 Vitamin E 1 Trastuzumab 1 Thioctic Acid 1 Thalidomide 1 Tadalafil 1 Surveys and Questionnaires 1 Rituximab 1 Radiosurgery 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04583124 2025-11-18

ATENTO

Universidad de Granada

Phase NA Completed

Breast Neoplasms, Neurotoxicity Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon ⚡